KaydedilenlerDerginizi ekleyin

Dergiler / Şişli Etfal Hastanesi Tıp Bülteni / 2007 / Cilt: 41 - Sayı: 3

Üriner sistem taş hastalığında medikal tedavi ve diyet

Mesrur Selçuk SILAY
Mustafa KADIHASANOĞLU
Cengiz MİROĞLU
Sayfa
7–12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

SILAY, M. S., KADIHASANOĞLU, M., MİROĞLU, C. (2007). Üriner sistem taş hastalığında medikal tedavi ve diyet. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 41 - Sayı: 3, 7–12. https://ajindex.com/articles/363894

Kaynakça (14)

  1. Pak CY5 Sakhaee K, Crowther C, et al: Evidence justifying a high fluid intake in treatment of nephrolithiasis. Ann Intern Med, 93:36-39, 1980
  2. Parks JH, Goldfischer ER, Coe FL: Changes in urine volume accomplished by physicians treating nephrolithiasis. J Urol, 169:863-866, 2003
  3. Schwartz BF, Schenkman NS, Bruce JE, et al: Calcium nephrolithiasis: effect of water hardness on urinary electrolytes. Urology, 60:23-27, 2002
  4. Coen G, Sardeîla D, Barbera G, et al: Urinary composition and lithogenic risk in normal subjects following oligomineral versus bicarbonate-alkaline high calcium mineral water intake. Urol Int, 67:49-53, 2001
  5. Shuster J, Jenkins A, Logan C, et al: Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol, 45: 911-916, 1992
  6. Robertson WG, Peacock M: The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980. Urol Int, 37:394-399,1982
  7. Wasserstein AG, Stolley PD, Soper KA, et al: Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab, 13:85-95, 1987
  8. Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain, and the risk of kidney stones. JAMA, 293:455-462,2005
  9. Ekeruo WO, Tan YH, Young MD, et al: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol, 172:159-163, 2004
  10. Straub M, Hautmann RE: Developments in stone prevention. Curr Opin Urol, 15:119-126, 2005
  11. Sakhaee K, Poindexter JR, Griffith CS, Pak CY: Stone forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol, 172:958-961,2004
  12. Traxer O, Huet B, Poindexter J, et al: Effect of ascorbic acid consumption on urinary stone risk factors. J Urol, 170:397-401, 2003
  13. Pak CY, Fuller C, Sakhaee K, et al: Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol, 136:1003-1008, 1986
  14. Rodman JS, Williams JJ, Jones RL: Hypercoagulability produced by treatment with acetohydroxamic acid. Clin Pharmacol Ther, 42:346-350,1987.